Cyprus
·

Ministry of Health: The 14 groups of citizens at risk for serious COVID19 disease (Catalog)

Untitled plan 51 Ministry of Health

At its base Decree of the Minister of Health, dated 4 November 2020, and following the recommendations of the Scientific Advisory Committee on Coronavirus, the list of categories of citizens at risk for serious disease from COVID-19, by adding category 14 as listed below.

It is noted that persons who fall into the following categories of citizens with risk factors for serious illness from COVID-19, and who are not employed in individual workplaces, but either come into contact with the public or work in a common workplace with other persons and there is no possibility to maintain the appropriate distances, then the competent Department / Service / Authority / Ministry takes the necessary internal arrangements so that these persons are able to carry out their work in an individual workplace.

  1. Pre-existing Chronic Respiratory Disease (eg severe bronchial asthma, patient undergoing chronic oxygen therapy or non-invasive ventilation [CPAP or BiPaP] at home, severe pulmonary hypertension (NYHA III and IV), severe pulmonary fibrosis, ).
  2. Severe Chronic Renal Failure (creatinine clearance below 15 ml / min and dialysis).
  3. Cardiac arrhythmia with permanent defibrillator or heart disease with permanent defibrillator and ventricular pacemaker.
  4. Heart Failure of any etiology (Ischemic or non-ischemic) stage according to NYHA III or IV.
  5. Cardiovascular disease:
  • Recent acute coronary syndrome or revascularization surgery: angioplasty or stent implantation in the last 12 months,
  • Aorto-coronary bypass (CABG (bypass)) in the last 12 months, and
  • Recent SLE in the last 12 months or with established neurological semiology.

6. Cardiopathies (History of documented myocarditis, hypertrophic, dilated, invasive (amyloidosis)).

7. Congenital heart disease after surgical correction with significant residual damage or non-corrected congenital heart disease with significant residual damage.

8. Active use of biological agents (eg TNF inhibitors, interleukin inhibitors) or other immunosuppressive drugs.

9. Active chronic corticosteroids (≥20mg prednisone or its equivalent for ≥ 1 month).

10. Patients with a history of solid organ or hematopoietic stem cell transplantation.

11. Patients with solid or hematologic malignancy receiving chemotherapy or radiation or immunotherapy.

12. Patients with HIV or patients with CD4 lymphocyte count <200 / mm3.

13. Hereditary or acquired immunodeficiencies.

14. Patients with Hemoglobinopathies falling into Category C - Patients with Very High Risk, according to the recommendations of the International Thalassemia Federation[1].

It is noted that the categories have been selected based on the existing international literature and taking into account the epidemiological data of the disease epidemic so far. COVID-19 in the international arena and in the Republic of Cyprus.